BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24806099)

  • 1. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.
    Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC
    Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
    Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
    World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience.
    Kamei H; Al-Basheer M; Shum J; Bloch M; Wall W; Quan D
    J Surg Res; 2013 Dec; 185(2):877-82. PubMed ID: 23953787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M; Dickson RC; Machicao VI; Aranda-Michel J; Keaveny A; Rosser B; Bonatti H; Krishna M; Yataco M; Satyanarayana R; Harnois D; Hewitt W; Willingham DD; Grewal H; Hughes CB; Nguyen J
    Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.
    Carmiel-Haggai M; Fiel MI; Gaddipati HC; Abittan C; Hossain S; Roayaie S; Schwartz ME; Gondolesi G; Emre S; Schiano TD
    Liver Transpl; 2005 Dec; 11(12):1567-73. PubMed ID: 16315297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent Outcomes With Retransplantation and Primary Liver Transplantation in the Direct-acting Antiviral Era.
    Croome KP; Mathur AK; Pungpapong S; Lee DD; Moss AA; Rosen CB; Heimbach JK; Taner CB
    Transplantation; 2019 Jun; 103(6):1168-1174. PubMed ID: 30247315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent liver retransplantation outcomes in hepatitis C-infected recipients.
    Kressel A; Therapondos G; Bohorquez H; Borg B; Bruce D; Carmody I; Cohen A; Girgrah N; Joshi S; Reichman T; Loss GE
    Clin Transplant; 2013; 27(4):E512-20. PubMed ID: 23859312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Cescon M; Varotti G; Ramacciato G; Vetrone G; Zanello M; Pinna AD
    Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Romano J; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3159-61. PubMed ID: 16213336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome.
    Yoo HY; Maheshwari A; Thuluvath PJ
    Liver Transpl; 2003 Sep; 9(9):897-904. PubMed ID: 12942450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
    Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
    Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
    Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
    Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
    J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center.
    Hong JC; Kaldas FM; Kositamongkol P; Petrowsky H; Farmer DG; Markovic D; Hiatt JR; Busuttil RW
    Ann Surg; 2011 Sep; 254(3):444-8; discussion 448-9. PubMed ID: 21817890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.